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A B S T R A C T
Under physiological conditions, vitamin C is the main antioxidant found in the central nervous system and is
found in two states: reduced as ascorbic acid (AA) and oxidized as dehydroascorbic acid (DHA). However, under
pathophysiological conditions, AA is oxidized to DHA. The oxidation of AA and subsequent production of DHA in
neurons are associated with a decrease in GSH concentrations, alterations in glucose metabolism and neuronal
death. To date, the endogenous molecules that act as intrinsic regulators of neuronal necroptosis under condi-
tions of oxidative stress are unknown. Here, we show that treatment with AA regulates the expression of pro- and
antiapoptotic genes. Vitamin C also regulates the expression of RIPK1/MLKL, whereas the oxidation of AA in
neurons induces morphological alterations consistent with necroptosis and MLKL activation. The activation of
necroptosis by AA oxidation in neurons results in bubble formation, loss of membrane integrity, and ultimately,
cellular explosion. These data suggest that necroptosis is a target for cell death induced by vitamin C.
1. Introduction
The reduced form of vitamin C, ascorbic acid (AA), is the main
antioxidant found in the central nervous system [1]. Under physiolo-
gical conditions, AA predominates and is taken up by neurons through
cotransporter sodium ascorbate 2 (SVCT2) [2]. When vitamin C fulfills
its antioxidant function, dehydroascorbic acid (DHA) is produced,
which diffuses into nerve cells by GLUTs transporters [3]. However,
under cerebral pathophysiological conditions, such as acoustic trauma
[4] or ischemia and reperfusion, AA is oxidized to DHA [5,6]. More-
over, patients with Alzheimer's disease have lower plasma concentra-
tions of vitamin C than healthy individuals [7] due to increased oxi-
dative stress [8], which could favor the production and accumulation of
DHA.
For many years, it has been thought that vitamin C could act as a
pro-oxidant and kill tumor cells [9–11]. In this context, it was recently
proposed that DHA could induce cell death directly in KRAS and BRAF
mutant colorectal cells [12] and in neuronal cells by triggering meta-
bolic crisis [3,13]. Irrespective of whether AA or DHA is the inducer of
cell death, it has been confirmed in the literature that vitamin C mainly
induces death independent of caspases with characteristics of necrotic
disintegration [9,14–16]. New and emerging forms of regulated cell
death with morphological characteristics of necrotic disintegration,
including ferroptosis [17,18] and necroptosis [19,20], have been re-
cently reported.
The execution of necroptosis requires that caspase-8 (Casp8) be
inhibited or absent [21]. RIPK1 also phosphorylates RIPK3 to activate
necroptosis by MLKL (mixed lineage kinase domain-like) phosphor-
ylation [22]. In the case of necroptosis, MLKL undergoes a conforma-
tional change following RIPK3-mediated phosphorylation (S345/S347/
T349 in mouse and S357/T358 in human) of the autoinhibitory C-
terminal pseudokinase domain. This change induces exposure of the
toxic N-terminal four helical bundle domain (4HBD), allowing the in-
teraction of positively charged patches with inositalhexaphosphate
(IP6) and phopshatidylinositolphosphates (such as PIP, PIP2), followed
by insertion and multimerization in the plasma membrane [23]. Then,
phosphatidyl serine is exposed, and pores are formed that trigger os-
motic stress and death by cell explosion [24–26]. MLKL-dependent cell
death by the necroptotic pathway induces the release of DAMP (da-
mage-associated molecular pattern), which promotes inflammation and
increases activation of necroptosis and other parallel death pathways
[27].
Necroptosis was of particular interest in the current study because
this type of death is induced in conditions of cerebral ischemia and
https://doi.org/10.1016/j.redox.2019.101408
Received 30 October 2019; Received in revised form 9 December 2019; Accepted 11 December 2019
∗ Corresponding author. Departamento de Biología Celular, Facultad de Ciencias Biológicas, Universidad de Concepción, Casilla 160-C, Concepción, Chile.
E-mail address: frnualart@udec.cl (F. Nualart).
Redox Biology 29 (2020) 101408
Available online 16 December 2019
2213-2317/ © 2019 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license 
(http://creativecommons.org/licenses/BY/4.0/).
T
reperfusion [20,28,29], Alzheimer's disease [30], and amyotrophic
lateral sclerosis (ALS) [31] in which oxidation of AA is favored [5–8].
Cerebral necroptosis is favored over apoptosis because the adult brain is
an organ refractory to apoptosis [32–34].
In this study, we determined that the intracellular oxidation of AA
favors the subsequent activation of necroptosis by phosphorylation of
MLKL. Furthermore, we analyzed the disintegration characteristics in
living cells by 4D microscopy, revealing that neuronal cells form ex-
tracellular vesicles prior to necroptotic disintegration in a manner si-
milar to that recently reported in the literature [24]. Finally, through
CRISPR/Cas9, we generated MLKL−/- and SVCT2−/− neuronal cells
and showed that ablation of MLKL delays cell death. Furthermore, if the
uptake of AA is inhibited by the deletion of SVCT2, neuronal death is
completely prevented. Our results suggest that the oxidation of vitamin
C and the generation of DHA could regulate neuronal necroptosis under
conditions of oxidative stress.
2. Methods
2.1. Compounds, antibodies, and reagents
The detailed information on the compounds, antibodies and re-
agents is listed in Supplementary Table 1. The secondary antibodies
included the following: Cy3 AffiniPure Donkey Anti-Goat IgG (H+L)
(705-165-147), Alexa Fluor 488 AffiniPure Donkey Anti-Rabbit IgG (H
+L) (711-545-152), Cy2 AffiniPure Donkey Anti-Mouse IgG (H+L)
(715-225-151), Cy5 AffiniPure Donkey Anti-Rabbit IgG (H+L) (711-
175-152), Alexa Fluor 488 AffiniPure Donkey Anti-Rat IgG (H+L)
(712-545-153), Cy3 AffiniPure Donkey Anti-Rat IgG (H+L) (712-165-
153), peroxidase-AffiniPure Goat Anti-Rabbit IgG (H+L) (111-035-
003) and AffiniPure Donkey Anti-Rat IgG (H+L) (712-005-153) were
purchased from Jackson ImmunoResearch (West Grove, PA, USA).
2.2. Cell lines
Primary cortical neurons were obtained from rat embryos at 17 days
gestation as previously described [3]. All the studies were approved by
the Animal Ethics Committee of the Chile's National Commission for
Scientific and Technological Research (CONICYT, approved protocol
#1181243). All animal studies were approved by the Animal Care and
Use Committee of the Universidad de Concepción. Animals were treated
in compliance with the NIH guidelines for animal care and use.
Neuro2a (N2a) cells (CCL-131) were obtained from American Type Cell
Collection (ATCC, Rockville, MD, USA) and maintained at 37 °C, 5% v/
v CO2 in a humidified incubator with DMEM-F12 (GIBCO) supple-
mented with 5% FBS (Mediatech, #MD.35-010-CV), 2 mM L-glutamine
(GIBCO) and 100 U/mL penicillin-streptomycin (GIBCO). HN33.11 cells
were cultured using DMEM-HG (GIBCO) under the same conditions. To
ensure mycoplasma-free cultures, the cells were treated with BM cyclin
(Roche, #10799050001) prior to experiments. N2a(Mlkl−/−) and
N2a(Svct2−/-) cells were generated by CRISPR/Cas9 using CAG-Cas9-2a-
RFP and Cas9-ElecD plasmids (Atum, #pD1321-AP) and transfection
with Lipofectamine 3000 (Life Technologies). The gRNA target se-
quences for the murine initiation codons of MLKL and SVCT2 were
GCACACGGTTTCCTAGACGC and TGTAGATCATATCCGACCTC, re-
spectively. The cells were selected at 48 h posttransfection using a BD
FACSAria III cell sorter. Single-cell RFP was sorted in 96-well plates.
MLKL- and SVCT2-deleted colonies were verified by Western blotting.
N2a-hSVCT2wt-EYFP, N2a-EGFP, HN33.11-hSVCT2wt-EYFP, and
HN33.11-EGFP cells were generated by infection with lentiviral parti-
cles as previously described [2]. Stable EYFP- and EGFP-expressing cells
were selected at 72 h postinfection by FACS.
2.3. Live-cell microscopy
N2a and HN33.11 cells were seeded in 18-mm cover glasses in 12-
well plates for 48 h. After treatment with H2O2, the cover was removed,
and the plates were placed in a live-cell perfusion chamber. Then, the
cells were loaded with fluorescent probes for 10 min and washed with
PBS. Finally, the cells were incubated in complete medium and imaged
at 37 °C and 5% CO2 in a confocal spectral Zeiss LSM 780 live-cell
system. The images were acquired in 4D (x: 1024, y: 1024, z: 6 or 10,
time, channels: 5, 8-bit) with an objective Plan-Apochromat 63x/1.40
Oil DIC M27. The following fluorescent probes were used: Hoechst
33342 (0.1 μg/mL, ex/em (nm) 350/461), Alexa Fluor 488 phalloidin
(20 nM, ex/em (nm) 495/518), MitoTracker Red CMXRos (25 nM, ex/
em (nm) 579/599), and cellmask (0.3X ex/em (nm) 650/655). Finally,
the images were reconstructed in a movie using the Zen lite software
(Zeiss).
2.4. Immunocytochemistry and image processing
Cells were seeded on coverslips. After treatment, the cells were fixed
with 4% paraformaldehyde for 30 min at room temperature, washed
with Tris-phosphate buffer [35] and incubated overnight at room
temperature with the following antibodies: anti-SVCT2 (1:50), anti-
GLUT1 (1:400), anti-RIPK1 (1:400), anti-RIPK3 (1:50), anti-MLKL
(1:400), anti-phospho RIPK1 (1:100) and anti-phospho MLKL (1:100).
The cells were incubated at room temperature for 2 h with Cy3 Affi-
niPure Donkey Anti-Goat IgG, Alexa Fluor 488 AffiniPure Donkey Anti-
Rabbit IgG, Cy2 AffiniPure Donkey Anti-Mouse IgG, Cy5 AffiniPure
Donkey Anti-Rabbit IgG, Alexa Fluor 488 AffiniPure Donkey Anti-Rat
IgG or Cy3 AffiniPure Donkey Anti-Rat IgG (1:200). Hoechst 33342
(1:1000) was used for nuclear staining. The images were acquired using
an LSM 780 spectral confocal microscope (Zeiss) or ELIRA S.1 Super-
resolution Structured Illumination Microscopy (Zeiss). The images were
exported in .czi format and processed in Imaris v 9.1 software (Bitplane
Inc) for 3D reconstruction, colocalization, morphology and bounding
box analysis. The intensity profile was determined with ImageJ soft-
ware.
2.5. Cell viability assay
N2a and HN33.11 cells were supplemented with 200 μM AA for
36 h. Then, intracellular oxidation of AA was induced by incubation
with 500 μM H2O2 for 30 min (or the concentration indicated in the
figure). After this time, H2O2 was removed, and the cells were washed
with PBS and incubated in complete medium for 3 h. Finally, cell via-
bility was measured by XTT (Biological Industries #20-300-1000) col-
orimetric analysis. Cell death by loss of plasma membrane integrity was
measured by flow cytometry (BD FACSAria III) with 500 nM TOPRO-3
(10 min) [36]. The flow cytometry data were processed with FlowJo
software (Tree Star). Nec-1, Nec-1s and zVAD.FMK were used during
and after treatment with H2O2.
2.6. Measurement of ROS
The cells were trypsinized, resuspended in serum-free DMEM-F12
(GIBCO), incubated for 30 min with 500 nM CellROX Deep Red (Life
Technologies) and analyzed by flow cytometry (BD FACSAria III). The
flow cytometry data were processed with FlowJo software (Tree Star).
2.7. Intracellular measurement of AA
The cells were washed with PBS, trypsinized and resuspended in
cold PBS. AA was measured using the ferric reducing (antioxidant)
activity and ascorbic acid concentration (FRASC) colorimetric assay
(bioassay system #EASC-100) according to the manufacturer's in-
structions.
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2.8. Western blot analysis
N2a and HN33.11 cells were lysed with NP-40 buffer supplemented
with a protease/phosphatase inhibitor cocktail (Cell Signaling #5872).
The proteins (30–50 μg) were separated using 10% SDS-PAGE gel,
transferred to PVDF membranes (0.45-μm pore; Immobilon-P
#IPVH00010, Merck Millipore) and probed with anti-SVCT2 (1:1000),
anti-RIPK1 (1:3000) and anti-MLKL (1:5000) overnight. The mem-
branes were then incubated with secondary antibodies, including HRP-
conjugated donkey anti-goat IgG, donkey anti-rabbit IgG, donkey anti-
rat IgG (1:6000) and anti-actin-HRP (1:50000) for 2 h at room tem-
perature. The reaction was developed using the Western Lighting® Plus-
ECL enhanced chemiluminescence substrate (PerkinElmer, Waltham,
MA, USA).
2.9. Quantification of proteins by flow cytometry
N2a and HN33.11 cells were trypsinized and fixed in 4% PFA at
room temperature for 10 min. Then, the cells were permeabilized in
100% cold methanol for 30 min. The cells were washed twice by cen-
trifugation in incubation buffer (0.5% BSA in Tris-phosphate buffer).
For immunostaining and resuspended in 100 μL of incubation buffer
with diluted RIPK1 (1:100) and MLKL (1:100) primary antibodies. After
1 h, the cells were washed by centrifugation and resuspended in Alexa
Fluor 488 AffiniPure Donkey Anti-Rabbit IgG (1:200) or Alexa Fluor
488 AffiniPure Donkey Anti-Rat IgG (1:200) secondary antibodies for
30 min. Finally, the cells were washed in incubation buffer, re-
suspended in PBS and analyzed by flow cytometry. The flow cytometry
data were processed with FlowJo software (Tree Star).
2.10. Real-time PCR
Total RNA from N2a and HN33.11 cells was purified using Trizol
reagent (Invitrogen, #15596018). Real-time PCR was performed with
Brilliant II SYBR® Green QPCR Master Mix (Agilent Technologies,
#600828). PCR (95 °C for 10 min; 95 °C for 30 s; 60 °C for 20 s; 72 °C
for 20 s; 40 cycles) was carried out in Mastercycler Realplex2
(Eppendorf). The primers used are listed in Supplementary Table 2. The
relative expression of mRNA to cyclophilin was calculated using the
2−ΔΔCt method.
2.11. Statistical analysis
Statistical analyses were performed using GraphPad Prism version
6.01. In the legend of each figure, the exact values of n of each analysis
are described. In all cases, two-tailed Student's t-tests were used. p-va-
lues ≤0.05 were considered statistically significant. Data are presented
as the means ± SEM.
3. Results
3.1. Intracellular AA oxidation induces neuronal death, balloon-like
morphology and subcellular redistribution of vitamin C transporters
To simulate the physiological brain conditions during which neu-
ronal cells accumulate AA [1,37], we supplemented in vitro cultures of
the neuronal N2a and HN33.11 cell lines and cortical neurons with
200 μM AA for 36 h, as shown in Fig. 1A. To favor the intracellular
oxidation of AA, we induced oxidative stress by glucose deprivation and
temporary addition of 0.5 mM H2O2 in N2a and HN33.11 cells and
50 μM H2O2 in cortical neurons for 30 min, after which the H2O2 was
removed. The cells were left in complete medium for 3 h to perform the
analyses (Fig. 1A). Using the FRASC method, we found that the cell
lines accumulated AA and that H2O2 treatment induced intracellular AA
oxidation over time (Fig. 1B and I). Furthermore, viability analyses with
XTT showed that oxidation of AA induced 50% neuronal death at 3 h
posttreatment in both cell lines and in cortical neurons (Fig. 1C and J,
S1F), whereas treatment with AA alone had no effect on cell viability
(Fig. S1A). Because the reduced form of vitamin C, AA, is transported by
SVCT2 in the brain and the transport of the oxidized form, DHA, is
mediated by GLUTs [1,38], we analyzed the presence of these trans-
porters by means of spectral confocal microscopy and superresolution
structured illumination microscopy (SIM). Our results showed that both
neuronal cell lines and cortical neurons expressed vitamin C transpor-
ters (Fig. 1D and K, S1G). However, when AA oxidation was induced in
N2a cells, subcellular vitamin C transporter redistribution was ob-
served: GLUT1 was detected in the perinuclear compartment, while
SVCT2 was primarily observed near the plasma membrane (Fig. 1D).
It has been reported that the morphological characteristics of ne-
croptosis in peripheral cells include a balloon-like morphology [26]. In
addition to inducing a change in the distribution of GLUT1/SVCT2 vi-
tamin C transporters, we observed that the oxidation of vitamin C in-
duced a drastic "balloon-like" morphological change in neuronal cells,
as revealed by 3D reconstruction using GLUT1 labeling (Fig. 1F, L,
Supplementary Videos 1 and 2). This change in cell morphology was
accompanied by the formation of bubble-like structures (Fig. 1M), a
morphological characteristic of cell death due to necroptosis [24].
Using live-cell microscopy and 3D reconstruction (Imaris v 9.1 soft-
ware, Bitplane Inc), we confirmed that treatment with TNF and zVAD
also induced a balloon-like morphology in neuronal cells (Figs. S1B and
S1E, Supplementary Video 3, video 4). On the other hand, 3D re-
construction analysis showed a perinuclear structure generated by
GLUT1 in the whole cell (Fig. 1E and F). To study this internal GLUT1
double-membrane structure in further detail, we analyzed GLUT1 with
superresolution SIM in 2D and 3D. Our data showed that the approx-
imate thickness of this double membrane structure is 100 nm and that
in the intermembrane space contains "trapped" SVCT2 (Fig. 1E). This
perinuclear double-membrane structure does not correspond to the
nuclear membrane because it does not colocalize with the nuclear la-
mina (Fig. S1C). In addition, we did not find increased expression of
SVCT2 or GLUT1 by qRT-PCR analysis (Fig. S1D). To examine cell size
changes, we used the bounding box tool, which identifies an object by
considering the minimal rectangular box that fully encloses the object,
whose faces are aligned parallel to the axes of a coordinate system.
Using this method, we observed that the oxidation of AA induces a
drastic change in cell size; in both cell lines, the cell lengths decreased
along the x and y axes, while the cell increased in length along the z axis
(Fig. 1H, O). The analysis of cell size and shape are closely related
because the loss of normal morphology (oblate, a spheroid with flat-
tened poles) is explained by the shortening of the x and y axes. The
spherical and prolate (an elongated spheroid) morphology is explained
by the increase in the length of the z axis (Fig. 1G, H, N, O).
Supplementary video related to this article can be found at https://
doi.org/10.1016/j.redox.2019.101408.
3.2. Vitamin C oxidation induces cell death by a mechanism independent of
ROS and apoptosis
The activation of necroptosis has been related to increased ROS
production in certain peripheral cell lines [26]. Thus, we evaluated the
production of ROS at different times by means of flow cytometry and
the CellROX Deep Red probe, which detects total cytoplasmic ROS. Our
results showed that the cell lines analyzed exhibited differential ROS
production. In N2a cells, H2O2 induced intracellular ROS production at
time 0 posttreatment (blue peak) (Fig. 2A and B).
As expected, at 3 and 4 h after treatment, the cells that were treated
with H2O2 exhibited increased ROS levels over time (blue peak)
(Fig. 2A and B). Unexpectedly, the cells that previously accumulated AA
exhibited higher levels of ROS (orange peak) (Fig. 2A and B). In N2a
cells in which AA had previously accumulated, we observed that two
cell populations were generated [1]: a cell population with low ROS
levels, probably due to the antioxidant effect of AA, and [2] a cell
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Fig. 1. Oxidation of vitamin C induced neuronal death and mor-
phological changes. (A) Schematic of the treatment protocol with
vitamin C and oxidative stress induction. (B and I) Intracellular
measurement of AA. The control condition represents the in-
tracellular concentration of AA prior to treatment with H2O2. The
time corresponds to the time in minutes posttreatment with H2O2.
n = 3 biologically independent samples. (C and J) Cell viability at
3 h posttreatment. (D and K) GLUT1 and SVCT2 distribution at 3 h
posttreatment. (E) 2D and 3D superresolution SIM of N2a cells at 3 h
posttreatment. (F and L) Imaris 3D reconstruction at 3 h posttreat-
ment. (G and N) Morphological analysis in N2a and HN33.11 cells.
(H and O) Cell size analysis with the Imaris bounding box tool. (M)
3D morphological alterations of the plasma membrane in
HN33.11 cells; the arrows show bubble-like structures.
Scale bar 10 μm. Data are shown as the mean ± SEM (two-tail
Student's t-tests); n = 3 biologically independent samples. All data
are representative of three separate experiments. *p ≤ 0.05,
**p ≤ 0.01, ***p ≤ 0.001.
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population with high levels of ROS (orange peak) (Fig. 2A and B),
which could eventually correspond to cells in the process of cell death.
In HN33.11 cells, we found that H2O2 or H2O2 + AA treatment did not
generate an increase in ROS production over time (Fig. 2C and D),
which could suggest that depending on the neuronal type, there are
different antioxidant mechanisms not necessarily related to vitamin C.
To determine if the production of ROS participates in the death-indu-
cing mechanism regulated by vitamin C, we inhibited ROS production
using the antioxidant N-acetyl-cysteine (NAC). However, our results
show that inhibition of ROS by NAC does not prevent neuronal death
under oxidative conditions of vitamin C (Fig. 2E and F), suggesting that
the mechanism of death is independent of ROS and the antioxidant
function of vitamin C. Finally, an effective dose of pan-caspase in-
hibitor, zVAD.FMK (Figs. S2A and S2B) did not protect against vitamin
C oxidation-mediated cell death (Fig. 2G and H), suggesting a non-
apoptotic mechanism. Thus, there are likely differential mechanisms of
activation of nonapoptotic cell death in the brain that do not necessarily
involve increased ROS production.
3.3. Supplementation with AA alters the expression of RIPK1, RIPK3 and
MLKL, favoring necroptosis under conditions of oxidative stress
AA is a cofactor of demethylases that regulates the expression of
different genes [39]. To examine whether nonapoptotic necrotic cell
death could involve an alternative mechanism of necroptosis induction,
we determined whether treatment with AA or the oxidation of AA could
affect the expression levels of apoptotic and necroptotic factors. In a
first approach, we evaluated the mRNA levels of apoptotic genes (bcl-2,
bax and casp8) and necroptotic genes (ripk1, ripk3, mlkl) by qRT-PCR.
Similar to previous studies [40–42], AA supplementation favored in-
hibition of apoptosis by overexpression of bcl-2 and suppression of bax
and casp8 mRNA expression (Fig. 3A and I). However, in cortical
neurons, treatment with AA did not alter the mRNA expression of bcl-2,
bax or casp8 (Fig. S3A). In contrast, intracellular accumulation of AA
favored a significant increase in the expression of RIPK1 mRNA (Fig. 3A
and I), whereas in cortical neurons, a significant increase in RIPK3
mRNA was observed (Fig. S3A). Interestingly, in the N2a cell line, ripk3
Fig. 2. ROS and apoptosis inhibition do not prevent cell death induced by vitamin C oxidation.(A and C) Intracellular ROS production in N2a and HN33.11 cells. (B
and D) Quantification of ROS production with respect to control (n = 2 biologically independent samples). (E and F) Cell viability analysis of ROS inhibition with N-
acetyl-cysteine (NAC, 24 h before treatment) in N2a and HN33.11 cells (n = 3 biologically independent samples). (G and H) Cell viability analysis of apoptosis
inhibition in N2a cells (n = 3 biologically independent samples).
Data are shown as the mean ± SEM (two-tail Student's t-tests); all data are representative of three separate experiments. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, n.s.,
not significant.
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mRNA was undetectable after AA treatment. With vitamin C oxidation,
RIPK3 mRNA expression increased by approximately 12-fold in N2a
cells and 3-fold in cortical neurons compared with the control condition
(Figs. 3A and S3A). At the protein level, we found that supplementation
with AA favored the expression of RIPK1 and MLKL (Fig. 3B and J).
Furthermore, quantification by flow cytometry showed that AA induced
RIPK1 protein expression by 70% (Fig. 3C and D), while MLKL ex-
pression increased by 50% in N2a cells (Fig. 3E and F). However, the
levels of RIPK1 and MLKL did not show significant changes in
HN33.11 cells (Fig. 3K–N).
We also analyzed the expression and intracellular distribution of
RIPK1, RIPK3 and MLKL proteins by confocal spectral microscopy. Our
immunocytochemical results maintained the same pattern of expression
described above at the mRNA level. However, redistribution to the
plasma membrane and the formation of filamentous structures of RIPK1
and MLKL were observed in the N2a cell line compared with AA sup-
plementation (Figs. 3G, H, S3D). This finding suggested that AA con-
trols other signals in addition to RIPK1 and MLKL expression that affect
their distribution. However, this distribution pattern was not observed
in HN33.11 cells or in cortical neurons (Fig. 3O, S3B). Conversely, H2O2
treatment did not alter the distribution of necroptotic proteins. In N2a
cells, H2O2 favored the expression of RIPK1 and MLKL (Fig. 3G),
whereas the opposite effect was observed in HN33.11 cells (Fig. 3O).
However, we observed that both cell lines responded to vitamin C
oxidation in a similar fashion, losing their processes, acquiring a "bal-
loon-like" morphology and increasing the expression of RIPK1, RIPK3
and MLKL (Fig. 3G, O). In addition, RIPK1 and MLKL were colocalized
in the plasma membrane (Fig. S3F), suggesting activation of the ne-
croptotic pathway by necrosome formation (Fig. 3G, O) and the bubble-
like structure containing MLKL and RIPK1 (Fig. S3E).
3.4. The oxidation of vitamin C induces neuronal necroptosis
Because AA oxidation induces neuronal death with a morphology
different from apoptosis, by a mechanism independent of caspases, and
by altering the expression of necroptotic genes and proteins, we ana-
lyzed this pathway using necrostatin-1 (Nec-1) or necrostatin-1s (Nec-
1s), an inhibitor of RIPK1 kinase activity. Interestingly, both Nec-1 and
Nec-1s prevented neuronal death induced by AA oxidation in a dose-
dependent manner (Fig. 4A and G, S3C). We report that high con-
centrations of Nec-1s can be used in primary cultures of cortical neu-
rons (Fig. S3C). In contrast, high concentrations of Nec-1 or Nec-1s
show only partial protection or toxicity in neuronal cell lines (Fig. 4A
and G, S3C), similar to results described by other groups [43,44]. The
execution of necroptosis was supported by the immunocytochemistry
finding of MLKL phosphorylation. Our data suggest that AA oxidation
induces phosphorylation and rapid MLKL nuclear translocation
(Fig. 4B, D, 4H) as well as cocolocalization of MLKL and P-MLKL at the
Fig. 3. Vitamin C regulates the expression of RIPK1, RIPK3 and MLKL, stimulating necroptosis. (A and I) mRNA levels of apoptotic and necroptotic genes. (B and J)
Expression of RIPK1 and MLKL in N2a and HN33.11 cells. (C and K) RIPK1 expression determined by flow cytometry (50,000 counts). (D and L) Relative quanti-
fication of RIPK1 by flow cytometry (n = 2 biologically independent samples). (E and M) MLKL levels determined by flow cytometry (50,000 counts). (F and N)
Relative quantification of MLKL by flow cytometry (n = 2 biologically independent samples). (G and O) Analysis of the expression and localization of RIPK1, RIPK3
and MLKL. (H). SIM superresolution of RIPK1 and MLKL in N2a cells treated with AA.
Scale bar 10 μm. Data are shown as the mean ± SEM (two-tail Student's t-tests). n = 3 biologically independent samples. The experiment was independently
reproduced three times. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, n.s. not significant.
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Fig. 4. Vitamin C oxidation induces neuronal necroptosis. (A and G) Necroptosis inhibition with Nec-1 or Nec-1s. (B and H) Microphotographs analyses of MLKL
phosphorylation. (C and I) Colocation map of MLKL/P-MLKL determined with Imaris. (D) Nuclear translocation of MLKL by phosphorylation. (E and J) Intensity
profile of MLKL/P-MLKL. (F and K) Quantification of MLKL phosphorylation.
Scale bar 10 μm. Data are shown as the mean ± SEM (two-tail Student's t-tests). n = 3 biologically independent samples. The experiment was independently
reproduced three times. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, n.s. not significant.
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Fig. 5. Neuronal vitamin C oxidation induces necroptotic disintegration features. (A and E) Schematic of the live/dead discrimination process. (B, C and D) Bubble
formation and features of disintegration during neuronal necroptosis. (F) Shedding of the cytoplasm and features of disintegration during neuronal necroptosis.
TOPRO-3 and phalloidin Alexa-488 were used as indicators of cell death by measuring plasma membrane integrity. Scale bar, 10 μm, for cortical neurons, 5 μm.
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plasma membrane (Fig. 4C and I) and in the whole cell (Fig. 4E and J).
Interestingly, we found that MLKL phosphorylation was more intense in
HN33.11 cells than in N2a cells (Fig. 4F and K).
3.5. Neuronal death induced by AA oxidation shares the characteristics of
necroptotic disintegration
Necroptosis has been morphologically characterized in peripheral
cells by induction of a balloon-like morphology, loss of mitochondrial
activity [26] and formation of bubbles in the plasma membrane [24],
triggering cellular explosion. Because AA oxidation induces neuronal
death due to RIPK1 kinase-mediated necroptosis, we evaluated the
characteristics of neuronal disintegration (Fig. 5A and E) by 4D live-cell
microscopy (x, y, z and time). N2a, HN33.11 cells and cortical neurons
maintained nuclear integrity, lost mitochondrial activity as measured
by MitotrackerCMXRos stain and formed bubbles permeable to phal-
loidin prior to the loss of plasma membrane integrity (Fig. 5B, C, 5D
Supplementary Videos 5, 6, 7), confirming that the released vesicles
corresponded to damaged plasma membrane. It should be noted that
the process of cell death and the formation of bubbles (Fig. 5B) were
faster in N2a cells than in HN33.11 cells (Fig. 5C) and cortical neurons
(Fig. 5D). However, both cell lines converged in that all cells lost
plasma membrane integrity, as observed by extending the imaging time
(Fig. 5C and F, Supplementary Video 8). Because the live image cell
analysis revealed a loss of mitochondrial membrane potential (Mito-
trackerCMXRos stain [45]), we confirmed that there was fragmentation
and alterations in the mitochondrial morphology in response to the
oxidation of vitamin C in N2a cells and cortical neurons (Figs. S4A–H,
S5A-J). However, inhibition of Drp-1 with Mdivi-1 did not prevent
neuronal death (Fig. S4J, S5L). Therefore, Drp-1 does not participate in
the neuronal necroptotic pathway as described in peripheral cells
[46,47].
Supplementary video related to this article can be found at https://
doi.org/10.1016/j.redox.2019.101408.
3.6. Overexpression of SVCT2 induces neuronal death in response to
oxidation of vitamin C, whereas MLKL−/- or SVCT2 −/− cells are
insensitive to neuronal death induced by vitamin C oxidation
The current data suggest that AA oxidation induces necroptosis. To
examine whether this effect is due to the uptake, accumulation and
subsequent oxidation of AA, we generated cells that stably over-
expressed the human vitamin C transporter, hSVCT2, by means of
lentiviral infection and subsequent selection by FACS (Fig. 6A and D).
Overexpression of hSVCT2 in neuronal cells greatly increased neuronal
death under oxidative conditions induced by H2O2 (Fig. 6C and F)
compared with the control cells, which were infected with a virus that
only expresses EGFP (Fig. 6B and E). Furthermore, we determined that
the effect of cell death is more accelerated in N2a cells (Fig. 6C) than in
HN33.11 cells (Fig. 6F).
Because the depletion of MLKL has been used to evaluate the in-
volvement of necroptosis in various models [24], we generated
MLKL−/- N2a cells through CRISPR/cas9 (Fig. 7A). The expression of
other components of the necroptotic pathway, such as RIPK1, was not
altered in MLKL−/- cells (Fig. 7A). Next, we analyzed whether the de-
pletion of MLKL prevents neuronal death induced by vitamin C. As
shown in Fig. 7E and F, neuronal death induced by the oxidation of
vitamin C was absent in MLKL−/- cells. Live-cell microscopy confirmed
the absence of morphological changes or plasma membrane perme-
ability in MLKL−/- cells at 3 h after treatment (Fig. S6A). Because other
research groups have shown that blockade of MLKL expression only
delays cell death in necroptotic conditions [48], we also analyzed cell
death in MLKL−/- cells at 6 h posttreatment and found increased cell
death independent of caspases, as the addition of zVAD did not prevent
cell death (Fig. S6B). Interestingly, when MLKL−/- cells were treated
with Nec-1, cell death was still observed at 6 h (Fig. S6B), suggesting
that MLKL-independent cell death is not mediated by RIPK1 kinase
activity.
To analyze the effect of AA uptake inhibition, we generated
SVCT2−/− N2a cells by CRISPR/cas9 (Fig. 7B). Using the FRASC
Fig. 6. Overexpression of hSVCT2 increases
neuronal death induced by vitamin C oxi-
dation. (A and D) SIM superresolution of
overexpression of hSVCT2. (B and E)
Quantification of cell death in stable N2a
and HN33.11 cells transduced with control
EGFP (30,000 count). (C and F)
Quantification of cell death in stable N2a
and HN33.11 cells transduced with
hSVCT2wt-EYFP (30,000 count).
Scale bar, 10 μm. Data are shown as the
mean ± SEM (two-tailed Student's t-tests).
n = at least two independent biological
replicates. The experiment was in-
dependently reproduced three times.
*p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, n.s.
not significant.
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method, we did not detect intracellular AA after three supplementations
with 200 μM AA every 12 h (data not shown). Using the previously
described oxidative stress induction protocol (Fig. 1A), neuronal death
induced by vitamin C oxidation was completely prevented (Fig. 7C). At
the same time, SVCT2−/− cells were highly sensitive to oxidative stress
induced by 0.5 mM H2O2 (Fig. 7C), which was not the case in wild-type
cells.
Following a dose response assay with decreasing concentrations of
H2O2 (Fig. 7D), we selected 50 μM H2O2 for subsequent experiments to
reach death rates similar to wild-type cells. When SVCT2−/− N2a cells
Fig. 7. MLKL or SVCT2 KO prevents cell death induced by vitamin C oxidation. (A and B) CRISPR/cas9 validation for MLKL and SVCT2. (C and D) Cell viability at 3 h
posttreatment in SVCT2−/− N2a cells. (E and F) Quantification of cell death in WT, MLKL−/- and SVCT2−/− N2a cells. (G) Schematic of the protocol used in Fig. H.
(H) Cell viability at 3 h posttreatment in SVCT2−/− N2a cells.
Data are shown as the mean ± SEM (two-tail Student's t-tests). n = 3 biologically independent samples. Each experiment was independently reproduced three
times. *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, n.s. not significant.
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were supplemented with AA to induce oxidative stress, cell death was
completely prevented (Fig. 7E and F), suggesting that cell death is de-
pendent on an intracellular mechanism of vitamin C accumulation and
oxidation. Interestingly, when SVCT2−/− N2a cells were subjected to
oxidative stress in the presence of DHA, which is incorporated into cells
through GLUTs but independent of SVCT2, as described in Fig. 7G,
neuronal death was induced (Fig. 7H). Thus, our data suggest that in-
tracellular AA is required for additional sensitization and eventual ne-
croptosis. At the same time, suggest that DHA is the molecule that in-
duces lethality in neurons.
4. Discussion
There are different data indicating that AA depletion (due to its
oxidation to DHA) could affect the activity of enzymes important for the
function of specific neurons in the CNS [38]. Among them, dopamine β-
Hydroxylase, which is essential in the synthesis of epinephrine, as well
as prolyl 4-hydroxylase (three isoenzymes) that participates in the hy-
droxylation of proline residues in hypoxia-inducible factor (HIF), could
be affected. Dysfunction of these enzymes can change neuronal meta-
bolism, inducing cell death [14]. In this work, we have analyzed how
oxidized vitamin C affects neuronal survival in conditions of oxidative
stress, inducing non-apoptotic cell death.
It has long been assumed that "vitamin C" (without discriminating
between AA and DHA redox states) can act as a pro-oxidant and induce
cell death due to oxidative stress associated with a Fenton reaction and
extracellular production of H2O2 [9,10], thereby inducing oxidative
necrotic cell death. However, our results suggest that there is an in-
tracellular mechanism of signal transduction regulated specifically by
the oxidized form of vitamin C, DHA, leading to necroptotic cell death.
The morphological changes induced by the oxidation of vitamin C from
our experiments in neurons resemble those that occur in peripheral
cells in response to TNF in the presence of the pancaspase inhibitor
zVAD-fmk [24,26]. However, it should be noted that in our experi-
mental conditions, the pathway of necroptosis does not require death
ligands. Thus, DHA could function as an intrinsic activator of ne-
croptosis. Furthermore, although several antioxidants have been used
to prevent cell death, our model suggests that the antioxidant function
of AA does not impact neuronal necroptosis because inhibition of ROS
by NAC does not prevent neuronal death, which is similar to the results
described by other research groups [20,29]. Interestingly, supple-
mentation of neurons with AA increased the expression and redis-
tribution (filamentous structures) of RIPK1 and MLKL in the absence of
oxidative stress. Regarding the increased expression of RIPK1 and its
redistribution, increased p-ERK levels promote the expression of RIPK1,
which may be associated with inhibition of apoptosis [49], while its
localization in the plasma membrane could correspond to ubiquitina-
tion [50]. Interestingly, previous results from our laboratory have
shown that AA is a potent inducer of ERK phosphorylation in neuronal
cells [2]. Thus, AA may activate ERK, thereby promoting RIPK1 ex-
pression and inhibiting death by apoptosis. Although little is known
about the mechanisms that control the expression of MLKL, our data
suggest that increased levels of MLKL may not be directly related to
death processes given that AA supplementation in the absence of oxi-
dative stress does not induce neuronal death (Fig. S1A). It is possible
that increased MLKL expression could be related to nonnecroptotic
functions, such as receptor-mediated endocytosis and exosome pro-
duction [51,52]. Deletion of MLKL only delayed but did not prevent cell
death in our study. In this context, the deletion of MLKL in the neuron
leads to a change from neuronal death dependent on RIPK1-MLKL to
RIPK1- and MLKL-independent neuronal death. We speculate that the
accumulation of DHA in the absence of MLKL could cause metabolic
crisis given that DHA is a potent inhibitor of hexokinase [53] and a
glycolysis inhibitor in neurons [3]. Thus, the accumulation of DHA in
cells deficient in MLKL could generate a change from necroptosis to
other nonapoptotic types of death, such as autosis, because DHA can
also act as an autophagy stimulator [54]. Thus, MLKL would not be the
best target for the prevention of neuronal death under pathophysiolo-
gical conditions. Previous studies have determined that DHA blocks the
activation of NFκB because it is a potent and specific inhibitor of IKKα/
β and p38 kinase activity in response to TNF-α [55,56]. Our results
suggest for the first time that the oxidation of AA to DHA results in
neuronal death due to the activation of necroptosis. We propose that
the regulatory mechanism would be through RIPK1 because its activity
can be inhibited by phosphorylation dependent upon IKK α/β [57].
Thus, RIPK1 can be inhibited in the cytosol by MAPK-activated protein
kinase 2 (MK2) independent of the activity of IKK α/β [58,59]. DHA
has been shown to specifically inhibit IKK α/β and p38 [55,56]. In view
of the role of IKK and the p38 MAPK-MK2 pathway in regulating sur-
vival function [57–59], it is conceivable that DHA may sensitize the
kinase-dependent cell death function of RIPK1, inducing inactivation of
MK2 by inhibiting p38. Our results also show that AA preconditions
cells for necroptosis because AA is an inhibitor of apoptosis. Thus,
under pathophysiological conditions in which AA is oxidized to form
DHA, DHA causes necroptotic cell death to be favored by preventing
apoptosis and sensitizing RIPK1-kinase activity. This dual effect of vi-
tamin C on survival would be dramatic in cells that have a low apop-
totic rate and that face acute oxidative stress conditions if they are able
to accumulate a high concentration of vitamin C. Unfortunately, neu-
rons accumulate more AA under physiological conditions (up to 10 mM
[1]) and are refractory to apoptosis [33,34,60]. In conclusion, under
pathophysiological conditions where the oxidation of neuronal AA is
favored, such as stroke, trauma, Alzheimer's disease, Huntington's dis-
ease, or Parkinson's disease, DHA could induce cell death via ne-
croptosis. Interestingly, our data suggest that SVCT2 exerts physiolo-
gical functions, ultimately controlling cerebral oxidative stress given
that its overexpression decreased the rate of cell death compared with
wild-type cells. In contrast, SVCT2−/− neurons were highly sensitive to
oxidative stress, suggesting that SVCT2 could be a marker of resistance
to cell death in the brain.
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